Trials / Completed
CompletedNCT01294722
A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea
The Prevalence of Out-patients With Rheumatoid Arthritis Fulfilling the Indication for Anti-tumor Necrosis Factor(TNFa) Therapy in General Hospital Setting in Korea: a Multi-center, Non-interventional, Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,700 (actual)
- Sponsor
- Janssen Korea, Ltd., Korea · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study to estimate the proportion of patients diagnosed with RA visiting a medical internist in a general hospital in Korea who are candidates for anti-TNF α therapy.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2011-02-11
- Last updated
- 2013-03-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01294722. Inclusion in this directory is not an endorsement.